The administration’s nomination of Antony Blinken is a good start. But mending the damage of the past four years will require a complete reorientation.
There’s been even more good news this week, this time from the Oxford-AstraZeneca trials. But a closer look reveals some very shaky science.
A holiday guide to navigating the deep swamp of polluted information.
Many of the communities most vulnerable to Covid-19 are the ones least willing to get a vaccine. Convincing them may require a peer-to-peer approach.
The impact of face coverings is not just unknown, it’s unknowable. Still, uncertainty should be no impediment to action.
The company wants to shut down an academic study of political ad targeting, just as it prepares to reinstate targeted political ads.
If we could watch what’s really going on in hospitals, there would be no more complacency.
An ER nurse’s anecdote of deranged denialism went viral. But when the media caught wind of the story, reporters didn’t do their jobs.
The plot of America is beginning to look a lot like those time travel stories in which society is just one squashed butterfly away from fascism.
YouTube is a major vector for election and other disinformation. But its CEO isn’t with Mark Zuckerberg and Jack Dorsey on Capitol Hill today.
Official guidance seems handed down from on high, rather than based on studies. That will make it harder to beat Covid-19.
It seems like a simple way to justify holiday gatherings. But the everyone-has-gotten-tested method is utterly absurd.
Hospitalizations for the disease are at their peak, but the death rate is way down. The simple procedure of flipping people over may be an important reason why.
The Biden administration should start by repairing alliances abroad and getting serious about regulation at home.
Just a few months ago, plenty of medical experts wanted to slow down the process for approving a Covid-19 vaccine. Given where things stand today, that would be a big mistake.